Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Once-Daily Prophylaxis in Hemophilia A
NCT00717626Phase 2Completed
- Sponsor
- SickKids
- Start
- Jul 2008
- Primary completion
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Factor VIII in hemophilia A, sponsored by SickKids. Primary endpoints: Hemophilia Joint Health Score 2.0 at 12 months, Functional Independence Score in Hemophilia at 12 months and 4 more. Started Jul 2008; status: completed.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00717626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717626.